Congress Crafting Bill To Modify Patent Challenges In Wake Of Allergan-Mohawk Deal
Executive Summary
House IP Subcommittee Chair Issa suggests legislation may address sovereign immunity and ways to make inter partes review process more palatable to patent owners.
You may also be interested in...
CREATES Act To Face Major Reshaping By Innovator-Friendly Amendments On Senate Floor
The Creating and Restoring Equal Access to Equivalent Samples Act clears US Senate Judiciary Committee. During markup, Sens. Hatch, R-Utah, and Cornyn, R-Tex., preview future amendments that would benefit innovators.
CREATES Act To Face Major Reshaping By Innovator-Friendly Amendments On Senate Floor
The Creating and Restoring Equal Access to Equivalent Samples Act clears US Senate Judiciary Committee. During markup, Sens. Hatch, R-Utah, and Cornyn, R-Tex., preview future amendments that would benefit innovators.
Will Inter Partes Review Go Away? Supreme Court Weighs Fate
Biopharma and generic industries stand on opposing sides in case that could eliminate the patent challenge proceeding. Interactive timeline covers IPR's five-year history leading to oral arguments Nov. 27.